Insider · SEC Form 4 filer
Lewis Titterton
Past buys: 2 of 4 beat
Companies
Where they file as an insider
Anixa Biosciences (ANIX) Director Latest filing Oct 23, 2026
Parkervision (PRKR) Director Latest filing Nov 18, 2025
Track record
Did their buys beat the typical stock?
Open-market buys24
Quarters checked 6 months later4
Beat the typical stock 2 of 4
Quarters too new to check3
2 of 4 checked quarters beat the typical stock. A past record is data, not a forecast.
Anixa Biosciences (ANIX) Bought Oct 23, 2026 · $23.8K · 8,000 shares Too new Too new. Its 6-month check uses prices as of Jun 30, 2027.
Anixa Biosciences (ANIX) Bought Jul 15–Sep 23, 2026 · $210K · 73,833 shares Too new Too new. Its 6-month check uses prices as of Mar 31, 2027.
Anixa Biosciences (ANIX) Bought Jun 16, 2026 · $7.49K · 2,836 shares Too new Too new. Its 6-month check uses prices as of Dec 31, 2026.
Parkervision (PRKR) Bought Nov 18, 2025 · $1M · 4.76M shares Not counted Not counted. We have no fund price for this stock on both Dec 31, 2025 and Jun 30, 2026.
Anixa Biosciences (ANIX) Bought Jul 11–31, 2025 · $62.2K · 20,000 shares Behind typical Sep 30, 2025 $3.30 → Mar 31, 2026 $2.58 · −21.8% (typical stock −3.4%)
Anixa Biosciences (ANIX) Bought Jan 17–24, 2025 · $56.1K · 21,000 shares Beat typical Mar 31, 2025 $2.86 → Sep 30, 2025 $3.30 · +15.4% (typical stock +7.3%)
Anixa Biosciences (ANIX) Bought Jul 25–31, 2024 · $110K · 35,722 shares Behind typical Sep 30, 2024 $3.15 → Mar 31, 2025 $2.86 · −9.2% (typical stock −7.5%)
Anixa Biosciences (ANIX) Bought Apr 9–Jun 14, 2024 · $108K · 37,584 shares Beat typical Jun 30, 2024 $2.21 → Dec 31, 2024 $2.32 · +5.0% (typical stock +3.9%)
Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.
Past results. This is data, not advice.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.